NRXP

Nrx Pharmaceuticals Stock Analysis

AI Rating

Low
  • Quality5/10
  • Growth↑ 5/10
  • Value↓ 0/10
Nrx Pharmaceuticals sales and earnings growth
NRXP Growth
Neutral
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 43.22%
  • FCF Y/Y↓ -32.67%
Nrx Pharmaceuticals gross and profit margin trends
NRXP Profitability
Good
  • Gross margin ↑ 58.80%
  • EPS margin↓ -2336.50%
  • ROIC 5Y↑ 672.44%
Nrx Pharmaceuticals net debt vs free cash flow
NRXP Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -41.7

Nrx Pharmaceuticals stock volatility is in-line with the overall market. We give it a Great risk rating.

↗ More Biotechnology stocks